Seborrheic Dermatitis

A scaly pink patch on the centre of the chest
A scaly pink patch on the centre of the chest

Table of Contents

  1. How Seborrheic Dermatitis Works
  2. Where It Appears
  3. Infant Cradle Cap
  4. Triggers and Worsening Factors
  5. Distinguishing from Psoriasis
  6. Antifungal Treatments
  7. Anti-Inflammatory Treatments
  8. Maintenance and Long-Term Management
  9. Key Research Papers
  10. Connections
  11. Featured Videos

How Seborrheic Dermatitis Works

Seborrheic dermatitis is a chronic, relapsing inflammatory skin condition that affects areas rich in sebaceous (oil-producing) glands. The word "seborrheic" means related to sebum, and "dermatitis" means skin inflammation. It is one of the most common skin conditions in adults. A 2024 worldwide pooled analysis of 121 studies (about 1.26 million people) put it at 4.38% of people overall: 5.64% of adults, 3.70% of children and 0.23% of newborns, with wide differences between countries.

The condition is closely linked to Malassezia yeast — particularly the species M. globosa and M. restricta — which live naturally on everyone's skin but cause inflammation in people with seborrheic dermatitis through an immune dysregulation. Malassezia breaks down sebum into free fatty acids that irritate the skin and trigger an exaggerated inflammatory response in susceptible individuals.

It typically follows a wax-and-wane pattern: flares during stress, cold weather, or illness, followed by periods of remission. It is not contagious and is not caused by poor hygiene. The scalp form — dandruff — is the mildest and most common presentation. The condition most commonly affects adults in their 30s to 60s and infants in the first months of life.

Where It Appears

Seborrheic dermatitis specifically targets areas with the highest concentration of sebaceous glands:

Infant Cradle Cap

Cradle cap (infantile seborrheic dermatitis) is extremely common in babies during the first weeks to months of life. It appears as thick, yellow or white greasy scales on the scalp, and occasionally involves the eyebrows, ears, and face. Unlike the adult form, cradle cap is not itchy and does not bother the baby.

The cause is thought to be lingering maternal hormones that stimulate the infant's sebaceous glands, combined with the normal Malassezia colonization that occurs shortly after birth.

Home care commonly described:

Cradle cap almost always resolves spontaneously by 6–12 months of age. It does not predict adult seborrheic dermatitis.

Triggers and Worsening Factors

Unlike many skin conditions, seborrheic dermatitis is strongly influenced by internal health factors, not just external irritants:

Distinguishing from Psoriasis

Seborrheic dermatitis and psoriasis can look similar on the scalp and face, and some patients have both — a condition called "sebopsoriasis." Key differences:

Antifungal Treatments

Since Malassezia yeast plays a central role, antifungal treatments are the cornerstone of seborrheic dermatitis therapy:

Anti-Inflammatory Treatments

For reducing redness and itch during flares — used alongside antifungals:

Maintenance and Long-Term Management

Seborrheic dermatitis cannot be permanently cured, but it can be effectively controlled with consistent maintenance therapy:

Key Research Papers

Key peer-reviewed studies on seborrheic dermatitis pathophysiology and treatment. Each PMID link opens the study on PubMed.

  1. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74(1):125-130. — PubMed PMID: 16848386
  2. Naldi L, Rebora A. Clinical practice. Seborrheic dermatitis. N Engl J Med. 2009;360(4):387-396. — PubMed PMID: 19164189
  3. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2):10. — PubMed PMID: 27148560
  4. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13-26. — PubMed PMID: 14678527
  5. Faergemann J. Pityrosporum infections. J Am Acad Dermatol. 1994;31(3 Pt 2):S18-20. — PubMed PMID: 8077501
  6. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011;4(5):32-38. — PubMed PMID: 21607192
  7. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343-351. — PubMed PMID: 23806151
  8. Rietcheck HR, Maghfour J, Rundle CW, Husayn SS, Presley CL, Sillau SH, Liu Y, Leehey MA, Dunnick CA, Dellavalle RP. A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson's Disease and the Potential Role of Oral Cannabinoids. Dermatology. 2021;237(6):872-877. — PubMed PMID: 33333525
  9. Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208(2):89-93. — PubMed PMID: 15056994
  10. Polaskey MT, Chang CH, Daftary K, Fakhraie S, Miller CH, Chovatiya R. The Global Prevalence of Seborrheic Dermatitis: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2024;160(8):846-855. — PubMed PMID: 38958996
  11. Blauvelt A, Draelos ZD, Stein Gold L, et al. Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial. J Am Acad Dermatol. 2024;90(5):986-993. — PubMed PMID: 38253129

Curated PubMed topic searches:

  1. PubMed: Ketoconazole treatment
  2. PubMed: Malassezia pathogenesis
  3. PubMed: Seborrheic dermatitis and HIV
  4. PubMed: Parkinson's disease association
  5. PubMed: Dandruff shampoo treatments
  6. PubMed: Infantile seborrheic dermatitis
  7. PubMed: Calcineurin inhibitors
  8. PubMed: Sebopsoriasis

Back to Table of Contents

Connections

Back to Table of Contents